These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 33895976)
1. Hyperuricemia and hypertriglyceridemia indicate tubular atrophy/interstitial fibrosis in patients with IgA nephropathy and membranous nephropathy. Liu B; Zhao L; Yang Q; Zha D; Si X Int Urol Nephrol; 2021 Nov; 53(11):2321-2332. PubMed ID: 33895976 [TBL] [Abstract][Full Text] [Related]
2. Hyperuricemia and its related histopathological features on renal biopsy. Fan S; Zhang P; Wang AY; Wang X; Wang L; Li G; Hong D BMC Nephrol; 2019 Mar; 20(1):95. PubMed ID: 30885171 [TBL] [Abstract][Full Text] [Related]
3. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients. Chai L; Cai K; Wang K; Luo Q J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of a diagnostic nomogram to evaluate tubular atrophy/interstitial fibrosis of IgA nephropathy. Gan Y; Cai Y; Li J; Wu J; Zhang R; Han Q; Li W; Yang Q Int J Med Sci; 2024; 21(4):674-680. PubMed ID: 38464822 [No Abstract] [Full Text] [Related]
5. The Related Factors of Hyperuricemia in IgA Nephropathy. Yi F; Lan L; Jiang J; Peng L; Jin Y; Zhou X Iran J Kidney Dis; 2021 Jul; 15(4):256-262. PubMed ID: 34278996 [TBL] [Abstract][Full Text] [Related]
6. [Retrospective Analysis of the Effect of Uric Acid on the Prognosis of Immunoglobulin A Nephropathy With Stage 3-4 Chronic Kidney Disease]. Yu Z; Qin Y; Yuan J; Zhao J; Sun S Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1121-1127. PubMed ID: 38162075 [TBL] [Abstract][Full Text] [Related]
7. Established the first clinical prediction model regarding the risk of hyperuricemia in adult IgA nephropathy. Geng YH; Zhang Z; Zhang JJ; Huang B; Guo ZS; Wang XT; Zhang LQ; Quan SX; Hu RM; Song CD; Duan FY; Liu YF Int Urol Nephrol; 2023 Jul; 55(7):1787-1797. PubMed ID: 36753014 [TBL] [Abstract][Full Text] [Related]
8. Plasma uric acid level indicates tubular interstitial leisions at early stage of IgA nephropathy. Zhou J; Chen Y; Liu Y; Shi S; Li X; Wang S; Zhang H BMC Nephrol; 2014 Jan; 15():11. PubMed ID: 24423013 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Characteristics, Role of Immunosuppressive Therapy and Progression in IgA Nephropathy with Hyperuricemia. Ruan Y; Hong F; Wu J; Lin M; Wang C; Lian F; Cao F; Yang G; Gao M Kidney Blood Press Res; 2018; 43(4):1131-1140. PubMed ID: 30016775 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features of IgA nephropathy patients with different levels of proteinuria. Ai Z; Xu R; Liu W; Zhou Q; Li B; Huang F; Yu X; Yang Q Clin Nephrol; 2016 Jul; 86(7):35-41. PubMed ID: 27251340 [TBL] [Abstract][Full Text] [Related]
11. The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy. Yang B; Zhou W; Cui L; Tian L; Ni Y; Yang M; Yang Y Front Endocrinol (Lausanne); 2024; 15():1372824. PubMed ID: 38808109 [TBL] [Abstract][Full Text] [Related]
12. Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy. Guan J; Wang M; Zhao M; Ni W; Zhang M BMC Nephrol; 2023 Mar; 24(1):60. PubMed ID: 36941570 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and associated factors of idiopathic membranous nephropathy with hyperuricemia: a single-centered cross-sectional study. Liang D; Zhang H; Lin Q; Wu X; Yang M; Dong H; Wang Y; Chen Z; Liu Y; Zhang X Int Urol Nephrol; 2023 Sep; 55(9):2275-2283. PubMed ID: 36867376 [TBL] [Abstract][Full Text] [Related]
14. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases. Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674 [TBL] [Abstract][Full Text] [Related]
15. Association of time-averaged serum uric acid level with clinicopathological information and long-term outcomes in patients with IgA nephropathy. Weng M; Fu B; Zhuo Y; Lin J; Zou Z; Chen Y; Cui J; Li G; Chen C; Xu Y; Jiang D; Wan J PeerJ; 2024; 12():e17266. PubMed ID: 38650643 [TBL] [Abstract][Full Text] [Related]
16. High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a. Moriyama T; Itabashi M; Takei T; Kataoka H; Sato M; Shimizu A; Iwabuchi Y; Nishida M; Uchida K; Nitta K J Nephrol; 2015 Aug; 28(4):451-6. PubMed ID: 25355499 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study. Liu S; Lu Z; Fu Z; Li H; Gui C; Deng Y Kidney Blood Press Res; 2023; 48(1):186-193. PubMed ID: 37062274 [TBL] [Abstract][Full Text] [Related]
18. Serum uric acid level is associated with glomerular ischemic lesions in patients with primary membranous nephropathy: an analytical, cross-sectional study. Yu Y; Zheng J; Li J; Li X; Liu Z; Yang R; Hong H; Zhang J Sci Rep; 2024 Mar; 14(1):7457. PubMed ID: 38548844 [TBL] [Abstract][Full Text] [Related]
19. A high value of fibrinogen in immunoglobulin A nephropathy patients is associated with a worse renal tubular atrophy/interstitial fibrosis score. Tu M; Hu S; Lou Z J Clin Lab Anal; 2022 Jan; 36(1):e24120. PubMed ID: 34783399 [TBL] [Abstract][Full Text] [Related]
20. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy. Wu C; Wang AY; Li G; Wang L BMC Nephrol; 2018 Dec; 19(1):381. PubMed ID: 30594167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]